3.1. Patient Characteristics and Recruitment
MYOCARDIAL INFARCTION, HYPERTENSION, DYSLIPIDEMIA
Thirty-three patients were included, 17 randomized for WPI and 16 for placebo. Eight patients were lost to follow-up, and only 15 and 10 patients, respectively, completed the 12 weeks of the study. The flowchart of patient inclusion and follow-up is depicted in Patients from both groups (WPI or placebo) were most frequently male, with hypertension, dyslipidemia, overweight/obesity, a history of myocardial infarction, mildly reduced mean LVEF, mostly in class I NYHA, and slightly elevated fasting glycemia and triglycerides (